Hopkinson Craig C. — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hopkinson Craig C. has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $7.47M.

Profile

Craig C. Hopkinson is an executive at Alkermes plc, serving as the Executive Vice President of Research and Development and Chief Medical Officer. He has extensive experience in the biotechnology sector, focusing on developing pharmaceutical products for unmet medical needs.

Board memberships

• Alkermes plc

Awards & honors

• Leadership in drug development
• Advancement of biotechnology innovations
• Strategic roles in pharmaceutical companies

Recent Transactions

Companies — Last 90 Days

• Alkermes plc. (ALKS) — 3 filings, last 2026-07-01

Frequently Asked Questions

Who is Hopkinson Craig C.?

Craig C. Hopkinson is an executive at Alkermes plc, serving as the Executive Vice President of Research and Development and Chief Medical Officer. He has extensive experience in the biotechnology sector, focusing on developing pharmaceutical products for unmet medical needs.…

How many SEC Form 4 filings has Hopkinson Craig C. submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Hopkinson Craig C. been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 17 open-market sales ($7.47M) across all tracked filings.

Where can I see all of Hopkinson Craig C.'s SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week